Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies

被引：56
作者：
Chakravarty, Soumya D. [1 ]
Yee, Arthur F.
Paget, Stephen A.
机构：
[1] Cornell Univ, Hosp Special Surg, Div Rheumatol, New York, NY 10021 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 128卷 / 06期
关键词：
CD203C; PATHOGENESIS; ACTIVATION; MARKER;
D O I：
10.1016/j.jaci.2011.08.023
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1354 / 1355
页数：3
相关论文
共 12 条
  • [1] Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria
    Arkwright, Peter D.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : 510 - 511
  • [2] Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients
    Binder, M
    Fierlbeck, G
    King, TP
    Valent, P
    Bühring, HJ
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 129 (02) : 160 - 168
  • [3] The basophil-specific ectoenzyme E-NPP3 (CD203c) as a marker for cell activation and allergy diagnosis
    Bühring, HJ
    Streble, A
    Valent, P
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 133 (04) : 317 - 329
  • [4] Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria
    Grattan, CEH
    O'Donnell, BF
    Francis, DM
    Niimi, N
    Barlow, RJ
    Seed, PT
    Black, AK
    Greaves, MW
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (02) : 365 - 372
  • [5] THE PATHOGENESIS OF CHRONIC IDIOPATHIC URTICARIA - NEW EVIDENCE SUGGESTS AN AUTOIMMUNE BASIS AND IMPLICATIONS FOR TREATMENT
    HIDE, M
    FRANCIS, DM
    GRATTAN, CEH
    BARR, RM
    WINKELMANN, RK
    GREAVES, MW
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (07) : 624 - 627
  • [6] Pathogenesis of chronic urticaria
    Kaplan, A. P.
    Greaves, M.
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2009, 39 (06) : 777 - 787
  • [7] Treatment of chronic autoimmune urticaria with omalizumab
    Kaplan, Allen P.
    Joseph, Kusumam
    Maykut, Robert J.
    Geba, Gregory P.
    Zeldin, Robert K.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) : 569 - 573
  • [8] Lack of response of severe steroid-dependent chronic urticaria to rituximab
    Mallipeddi, R.
    Grattan, C. E. H.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (03) : 333 - 334
  • [9] Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
    Maurer, Marcus
    Altrichter, Sabine
    Bieber, Thomas
    Biedermann, Tilo
    Braeutigam, Matthias
    Seyfried, Stefan
    Brehler, Randolf
    Grabbe, Juergen
    Hunzelmann, Nicolas
    Jakob, Thilo
    Jung, Andreas
    Kleine-Tebbe, Joerg
    Mempel, Martin
    Meurer, Michael
    Reich, Kristian
    Rueff, Franziska
    Schaekel, Knut
    Sengupta, Kaushik
    Sieder, Christian
    Simon, Jan C.
    Wedi, Bettina
    Zuberbier, Torsten
    Mahler, Vera
    Staubach, Petra
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (01) : 202 - U326
  • [10] LYMPHOCYTE SUBPOPULATIONS IN THE SKIN OF PATIENTS WITH CHRONIC URTICARIA
    MEKORI, YA
    GIORNO, RC
    ANDERSON, P
    KOHLER, PF
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1983, 72 (06) : 681 - 684
12